ACTRN12615001208594已完成1 期
Single-centre, single-dose, open-label, randomised, four-way cross-over study to evaluate and compare the pharmacokinetic parameters of a fixed dose combination of intravenous acetaminophen + intravenous ibuprofen, intravenous acetaminophen, intravenous ibuprofen and a fixed dose combination tablet of acetaminophen 325mg + ibuprofen 97.5mg, in healthy volunteers.
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
This study confirmed that for the fixed dose combination Maxigesic IV (acetaminophen 1000mg + ibuprofen 300mg/100mL) the maximum blood levels and the time profile of the drugs in the body is similar to either drug by itself (acetaminophen 1000mg /100mL or ibuprofen 300mg/100mL) when administered by intravenous infusion. Overall exposure to acetaminophen and ibuprofen was similar between Maxigesic IV and Maxigesic 325 tablets (Acetaminophen 975mg + ibuprofen 292.5mg). However, as expected the maximum blood level of both drugs was higher when administered by intravenous infusion compared to oral administration.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 50 Years（—）
- 性别
- All
入选标准
- •Healthy volunteers, males and females aged 18 to 50 years of age. Females must be sterile or using adequate contraception. Participants must not have taken any medications for at least 14 days before the start of each study phase, with the exception of oral contraceptives.
- •All volunteers must be deemed healthy on the basis of a medical history, physical exam (including vital signs and ECG recording), urinalysis, and blood biochemical and haematological examinations.
排除标准
- •1..Women who are pregnant or nursing.
- •2. Women of childbearing potential who are unwilling to take adequate contraceptive precautions, i.e., a hormonal contraceptive, an intrauterine device, double-barrier method, or abstinence. A woman of childbearing potential is defined as any female who is less than 2 years post-menopausal or has not undergone a partial or total hysterectomy or surgical sterilisation, e.g. bilateral tubal ligation, bilateral oophorectomy.
- •3. Women of childbearing potential who are unwilling to undergo a urine pregnancy test.
- •4. Have an alcohol intake in excess of 14 units per week for females and 21 units per week for males.
- •5. Have a history of drug abuse or positive test results for drug abuse.
- •6. Is a current smoker.
- •7. Have used prescription drugs (not including oral contraceptives) within 14 days prior to study drug administration or have used over-the-counter drugs herbal products or vitamins within 7 days prior to study drug administration, unless the Principal Investigator and Sponsor agree that the product taken will not impact on study conduct, results or participant safety.
- •8. Currently, or in last 30 days, participating in a clinical trial involving another study drug
- •9. Have donated blood or blood products within 30 days prior to study drug administration
- •10. Have a clinically significant abnormal laboratory test (as determined by the Principle Investigator)
- •11. Suffering from any other diseases or condition which, in the opinion of the investigator, means that it would not be in the participant’s best interests to participate in this study
- •12. Have any history of allergy or hypersensitivity to ibuprofen, aspirin or other NSAID
- •13. Have any history of allergy or hypersensitivity to acetaminophen
- •14. Have severe known haemopoetic, renal or hepatic disease, immunosuppression
- •15. Have a history of gastric ulceration, indigestion, stomach pain or GI bleeding or bleeding disorders
- •16. Currently suffering from dehydration through diarrhoea and/or vomiting
- •17. Have a history of severe asthma defined as previous steroid treatment or hospital admission within the last 5 years
研究者
相似试验
已完成
3 期
Maxi-Analgesic Junior StudyChildren requiring analgesia post tonsillectomySurgery - Pain managementACTRN12607000005459Hartley Atkinson, Managing Director, AFT Pharmaceuticals, Ltd152
已完成
3 期
A study comparing the effects of a combination of paracetamol and ibuprofen with paracetamol alone or ibuprofen alone or placeboPost-operative pain from arthroscopy surgery of the kneeAnaesthesiology - Pain managementACTRN12611000952943AFT Pharmaceuticals Ltd.300
已完成
2 期
Maxigesic Oral Suspension for Children undergoing TonsillectomyACTRN12615000456550AFT pharmaceuticals Ltd253
撤回
3 期
A Multiple-Dose Safety Study of Fixed Combination of Acetaminophen/Naproxen Sodium in Adolescents With Orthodontic PainOrthodontic PainNCT05845008Johnson & Johnson Consumer Inc. (J&JCI)
Unknown
1 期
Study to Evaluate the Safety and PK of UI018Hyperlipemia, MixedNCT05085184Korea United Pharm. Inc.44